Biotech · Private company
Hummingbird Bioscience
Track this companyFree. Adds Hummingbird Bioscience to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ENV-501Phase 2 · Melanoma (Skin)ClinicalTrials.gov · fetched Nov 12, 2026
- HMBD-002Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid TumorsPHASE1_PHASE2 · RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT06956690 · fetched Nov 12, 2026
- A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Feb 28, 2022ClinicalTrials.gov NCT05082610 · fetched Nov 12, 2026